On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Biotechpharma's own share of each project, not the project's full budget.
- Horizon 2020€845k · 1 project
Projects
1 EU-funded project, newest first. Each links to the official record.
- PANAPartner
PROMOTING ACTIVE AGEING: FUNCTIONAL NANOSTRUCTURES FOR ALZHEIMER’S DISEASE AT ULTRA-EARLY STAGES.
Horizon 2020 · 2016–2021 · Project on CORDIS ↗
€845ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Katholieke Universiteit LeuvenBelgium · 1 shared project
- Agencia Estatal Consejo Superior de Investigaciones CientificasSpain · 1 shared project
- Stichting VuNetherlands · 1 shared project
- Stichting Amsterdam UmcNetherlands · 1 shared project
- Ita-Suomen YliopistoFinland · 1 shared project
- Universidad de Santiago de CompostelaSpain · 1 shared project
- International Iberian Nanotechnology LaboratoryPortugal · 1 shared project
- Servizo Galego de SaudeSpain · 1 shared project
- Fundacion Instituto de Estudios de Ciencias de la Salud de Castilla y LeonSpain · 1 shared project
- Stab Vida Investigacao e Servicos Em Ciencias Biologicas LdaPortugal · 1 shared project
- reMYND NVBelgium · 1 shared project
- Roche Diagnostics SLSpain · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- alzheimer
- immunotherapy
- nuclear medicine
- pathology
- pharmaceutical drugs
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.